These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38732253)

  • 21. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress.
    Cai W; Chong K; Huang Y; Huang C; Yin L
    Redox Biol; 2024 Feb; 69():103010. PubMed ID: 38160540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.
    Chen D; Ruan X; Liu Y; He Y
    Bioengineered; 2022 May; 13(5):11417-11429. PubMed ID: 35506308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the impact of diabetes and diabetic cardiomyopathy rat heart on the outcome of ischemia-reperfusion associated oxidative stress.
    Mahalakshmi A; Kurian GA
    Free Radic Biol Med; 2018 Apr; 118():35-43. PubMed ID: 29462717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic Cardiovascular Disease Induced by Oxidative Stress.
    Kayama Y; Raaz U; Jagger A; Adam M; Schellinger IN; Sakamoto M; Suzuki H; Toyama K; Spin JM; Tsao PS
    Int J Mol Sci; 2015 Oct; 16(10):25234-63. PubMed ID: 26512646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy.
    Dhar A; Venkadakrishnan J; Roy U; Vedam S; Lalwani N; Ramos KS; Pandita TK; Bhat A
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231210170. PubMed ID: 38069578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
    Parim B; Sathibabu Uddandrao VV; Saravanan G
    Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
    Peng ML; Fu Y; Wu CW; Zhang Y; Ren H; Zhou SS
    Front Endocrinol (Lausanne); 2022; 13():907757. PubMed ID: 35784531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
    Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
    Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway.
    Yao R; Cao Y; Wang C; Xu L; Zhang X; Deng Y; Li F; Wang S
    BMC Complement Med Ther; 2021 Feb; 21(1):78. PubMed ID: 33637069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways.
    Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W
    J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
    Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic Cardiomyopathy: Clinical and Metabolic Approach.
    Djordjevic DB; Koracevic G; Djordjevic AD; Lovic DB
    Curr Vasc Pharmacol; 2021; 19(5):487-498. PubMed ID: 33143612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.
    Sukumaran V; Gurusamy N; Yalcin HC; Venkatesh S
    Pflugers Arch; 2022 Jan; 474(1):63-81. PubMed ID: 34967935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
    Ansari M; Kurian GA
    Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy.
    Tang Z; Wang P; Dong C; Zhang J; Wang X; Pei H
    Oxid Med Cell Longev; 2022; 2022():5913374. PubMed ID: 35103095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dysfunction plays a key role in the abrogation of cardioprotection by sodium hydrosulfide post-conditioning in diabetic cardiomyopathy rat heart.
    A M; Kurian GA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):339-348. PubMed ID: 31624852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.